DNA Script
Transforming how molecular biology translates to human health, personalized medicine, and synthetic biology.
Launch date
Employees
Market cap
-
Enterprise valuation
€750m (Public information from Jan 2022)
Company register number 801172834
Le Kremlin-Bicêtre Île-de-France (HQ)
Financials
Estimates*
| EUR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenues | - | <1m | 1.0m | 1.7m | 4.8m | 7.6m | 9.3m |
| % growth | - | - | 10199 % | 68 % | 183 % | 59 % | 22 % |
| EBITDA | - | (4.2m) | (5.4m) | (11.9m) | (26.9m) | - | - |
| % EBITDA margin | - | (42551 %) | (537 %) | (702 %) | (561 %) | - | - |
| Profit | (1.3m) | (3.8m) | (5.2m) | (12.9m) | (28.7m) | - | - |
| % profit margin | - | (38476 %) | (512 %) | (759 %) | (598 %) | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
* | N/A | Spinout | |
* | N/A | Support Program | |
€2.5m | Seed | ||
* | €11.0m | Series A | |
* | $5.5m | Grant | |
* | $2.7m | Grant | |
$38.5m | Series B | ||
$50.0m | Series B | ||
$165m | Series C | ||
* | $35.0m Valuation: $825m 156.4x EV/LTM Revenues -27.9x EV/LTM EBITDA | Series C | |
| Total Funding | €283m | ||
Related Content
Recent News about DNA Script
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.